Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors
Background Targeting epidermal growth factor receptor (EGFR) has become a strategic approach in cancer therapy, using various modalities including chimeric antigen receptor (CAR)-αβT cell therapies. Despite significant advancements in autologous CAR-αβT cell therapies in B-cell lymphoma, current cel...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
BMJ Publishing Group
2025-07-01
|
| 叢編: | Journal for ImmunoTherapy of Cancer |
| 在線閱讀: | https://jitc.bmj.com/content/13/7/e010500.full |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|